FUND
SCBGENOME(SSFE)
SCB Genomic Revolution
SSF · deduct up to ฿200K
Risk level 7 of 8 · fee 0.60% a year · Hold ≥10 years from each investment date
Source: Thai SEC (Open Data) · NAV as of 20 Oct 2026
What it invests in
Equity fund · SSF
SEC policy: ตราสารทุน
Risk
Risk levelLevel 7 of 8
Very high (sector / foreign equity)
Fees
Expense ratioDeducted from the fund every year0.60%
Before you invest
SSF
Hold ≥10 years from each investment date
Deduction caps can change every year. Check with the Revenue Department or the fund manager before deciding
NAV chart
Daily NAV per unit of this class, from the Thai SEC; pick a window
+฿1.75 (+48.2%)over 1 year
Source: end-of-day closes from Jul 30, 2025 to Oct 20, 2026 · a record of past closes for study, not a forecast and not investment advice
NAV & size
NAV per unitas of 20 Oct 2026 · the NAV chart's last point฿5.3757
Fund size (AUM)฿45M
Overview
Asset managerSCB ASSET MANAGEMENT COMPANY LIMITEDSCBAM
Registered inThailand
Tax benefitSSF
Inception20 Aug 2021
Returns published by the Thai SEC
Year-to-date+60.1%
1-year return+82.9%
3-year return+10.8%
5-year return−13.8%
Since inception
For study, not investment advice · returns are past figures published by the Thai SEC; past performance does not tell you future performance · the tax deduction follows the Revenue Code